KR910002566B1 - 2,3,4,5,6,7-헥사하이드로-2,7-메타노-1,5-벤조옥사조닌 및 -1,4-벤조옥사조닌 화합물들, 이들의 제조방법 및 이들을 포함하는 약학적 조성물 - Google Patents

2,3,4,5,6,7-헥사하이드로-2,7-메타노-1,5-벤조옥사조닌 및 -1,4-벤조옥사조닌 화합물들, 이들의 제조방법 및 이들을 포함하는 약학적 조성물 Download PDF

Info

Publication number
KR910002566B1
KR910002566B1 KR1019870009863A KR870009863A KR910002566B1 KR 910002566 B1 KR910002566 B1 KR 910002566B1 KR 1019870009863 A KR1019870009863 A KR 1019870009863A KR 870009863 A KR870009863 A KR 870009863A KR 910002566 B1 KR910002566 B1 KR 910002566B1
Authority
KR
South Korea
Prior art keywords
hydrogen atom
compound
atom
hydrogen
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019870009863A
Other languages
English (en)
Korean (ko)
Other versions
KR880003945A (ko
Inventor
후리드리히 아이덴 독토르
페터 지마이너 독토르
왤건 쉬네만 독토르
Original Assignee
마다우스 아크티엔 게젤샤프트
독토르 롤프 마다우스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마다우스 아크티엔 게젤샤프트, 독토르 롤프 마다우스 filed Critical 마다우스 아크티엔 게젤샤프트
Publication of KR880003945A publication Critical patent/KR880003945A/ko
Application granted granted Critical
Publication of KR910002566B1 publication Critical patent/KR910002566B1/ko
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR1019870009863A 1986-09-08 1987-09-07 2,3,4,5,6,7-헥사하이드로-2,7-메타노-1,5-벤조옥사조닌 및 -1,4-벤조옥사조닌 화합물들, 이들의 제조방법 및 이들을 포함하는 약학적 조성물 Expired KR910002566B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3630539.1 1986-09-08
DE19863630539 DE3630539A1 (de) 1986-09-08 1986-09-08 Derivate von 2,3,4,5,6,7-hexahydro-2,7-methano-1,5-benzoxazonin (bzw. -1,4-benzoxazonin), verfahren zu ihrer herstellung und arzneimittel, die diese verbindung enthalten

Publications (2)

Publication Number Publication Date
KR880003945A KR880003945A (ko) 1988-05-31
KR910002566B1 true KR910002566B1 (ko) 1991-04-26

Family

ID=6309142

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870009863A Expired KR910002566B1 (ko) 1986-09-08 1987-09-07 2,3,4,5,6,7-헥사하이드로-2,7-메타노-1,5-벤조옥사조닌 및 -1,4-벤조옥사조닌 화합물들, 이들의 제조방법 및 이들을 포함하는 약학적 조성물

Country Status (29)

Country Link
US (1) US4859664A (enExample)
JP (1) JPS6377882A (enExample)
KR (1) KR910002566B1 (enExample)
CN (1) CN1020103C (enExample)
AR (1) AR243190A1 (enExample)
AT (1) ATA185987A (enExample)
AU (1) AU590443B2 (enExample)
BE (1) BE1002121A4 (enExample)
CH (1) CH675723A5 (enExample)
CS (1) CS621687A2 (enExample)
DD (1) DD275052A1 (enExample)
DE (1) DE3630539A1 (enExample)
DK (1) DK464487A (enExample)
ES (1) ES2013322A6 (enExample)
FI (1) FI88800C (enExample)
FR (1) FR2603587B1 (enExample)
GB (1) GB2194786B (enExample)
GR (1) GR871209B (enExample)
HU (1) HU203106B (enExample)
IL (1) IL83156A (enExample)
IT (1) IT1228437B (enExample)
NL (1) NL8701938A (enExample)
NO (1) NO168530C (enExample)
PL (1) PL154258B1 (enExample)
PT (1) PT85656B (enExample)
SE (1) SE8703343L (enExample)
SU (1) SU1565346A3 (enExample)
YU (1) YU46068B (enExample)
ZA (1) ZA876657B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4963547A (en) * 1988-06-01 1990-10-16 Smithkline Beecham Corporation Alpha-andrenergic receptor antagonists and use thereas
CA1320486C (en) * 1988-06-01 1993-07-20 John J. Lafferty .alpha. -adrenergic receptor antagonists
DE68919280T2 (de) * 1988-06-01 1995-03-23 Smithkline Beckman Corp Alpha-adrenergische Rezeptorantagonisten.
US4959360A (en) * 1988-06-01 1990-09-25 Smithkline Beecham Corporation α-adrenergic receptor antagonists
ATE109483T1 (de) * 1988-06-01 1994-08-15 Smithkline Beecham Corp Alpha-adrenergische rezeptorantagonisten.
DE4102103A1 (de) * 1991-01-25 1992-08-20 Bayer Ag Substituierte benzoxazepine und benzthiazepine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
US5248645A (en) * 1992-09-01 1993-09-28 Phillips Petroleum Company Ethylene oligomerization

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124583A (en) * 1964-03-10 Substituted derivatives of
US3118900A (en) * 1962-01-15 1964-01-21 Abbott Lab Substituted derivatives of 3-aza-6, 7-benzo-8-oxa-5-phenylbicyclo[3.3.1]-nonane
US3401166A (en) * 1966-08-01 1968-09-10 Squibb & Sons Inc Therapeutically active benzothiazines
US3446820A (en) * 1967-04-03 1969-05-27 Rexall Drug Chemical Substituted benzoxazocines and intermediates
US3869475A (en) * 1973-04-05 1975-03-04 Yissum Res Dev Co 2,6-methano-benzoxacin compounds
JPS50106985A (enExample) * 1973-05-08 1975-08-22
US4100277A (en) * 1976-11-08 1978-07-11 American Home Products Corporation 4,1-Benzoxazonine derivatives and process therefor
US4315006A (en) * 1979-08-09 1982-02-09 Glaxo Group Limited Benzoxocin derivatives having anxiolytic and anti-convulsant activities

Also Published As

Publication number Publication date
FI873852L (fi) 1988-03-09
GB2194786B (en) 1991-01-02
NO168530B (no) 1991-11-25
NO168530C (no) 1992-03-04
DK464487A (da) 1988-03-09
BE1002121A4 (fr) 1990-07-17
HU203106B (en) 1991-05-28
ATA185987A (de) 1994-05-15
HUT50180A (en) 1989-12-28
FI88800B (fi) 1993-03-31
NL8701938A (nl) 1988-04-05
PT85656B (pt) 1990-05-31
IL83156A (en) 1992-12-01
AU7816287A (en) 1988-03-10
FR2603587B1 (fr) 1991-02-01
PL154258B1 (en) 1991-07-31
ES2013322A6 (es) 1990-05-01
SE8703343L (sv) 1988-03-09
ZA876657B (en) 1988-03-08
AU590443B2 (en) 1989-11-02
DE3630539A1 (de) 1988-03-10
IL83156A0 (en) 1987-12-31
JPS6377882A (ja) 1988-04-08
PT85656A (en) 1987-10-01
JPH0319236B2 (enExample) 1991-03-14
CN1020103C (zh) 1993-03-17
NO873727D0 (no) 1987-09-07
DK464487D0 (da) 1987-09-07
FR2603587A1 (fr) 1988-03-11
FI88800C (fi) 1993-07-12
DD275052A1 (de) 1990-01-10
FI873852A0 (fi) 1987-09-07
GB8716668D0 (en) 1987-08-19
KR880003945A (ko) 1988-05-31
IT8721436A0 (it) 1987-07-24
PL267628A1 (en) 1989-06-12
AR243190A1 (es) 1993-07-30
GB2194786A (en) 1988-03-16
CN87106267A (zh) 1988-04-13
GR871209B (en) 1987-11-30
CS621687A2 (en) 1990-09-12
CH675723A5 (enExample) 1990-10-31
SE8703343D0 (sv) 1987-08-28
NO873727L (no) 1988-03-09
SU1565346A3 (ru) 1990-05-15
IT1228437B (it) 1991-06-17
US4859664A (en) 1989-08-22
YU46068B (sh) 1992-12-21

Similar Documents

Publication Publication Date Title
AU654653B2 (en) Therapeutically useful 2-aminotetralin derivatives
JPH0570463A (ja) Ｎ−アシル−２，３−ベンゾジアゼピン誘導体、その製造法、それを含有する製剤組成物、およびその製造法
JPH0819065B2 (ja) ベンゾ融合シクロアルカンおよびオキサ‐およびチア‐シクロアルカントランス‐１，２‐ジアミン誘導体
AU2001264116B2 (en) Amidine derivatives as selective antagonists of NMDA receptors
AU2001264116A1 (en) Amidine derivatives as selective antagonists of NMDA receptors
FI106797B (fi) Menetelmä atsabisyklo [2.2.1] heptan-3-onioksiimien valmistamiseksi
JPH04338383A (ja) 置換されたベンゾキサゼピン類及びベンゾチアゼピン類
KR910002566B1 (ko) 2,3,4,5,6,7-헥사하이드로-2,7-메타노-1,5-벤조옥사조닌 및 -1,4-벤조옥사조닌 화합물들, 이들의 제조방법 및 이들을 포함하는 약학적 조성물
EP0167901A2 (en) Active compounds
KR20070064437A (ko) 환상 아민 유도체 또는 그의 염
JPS6135175B2 (enExample)
EP1664017A1 (en) Benzimidazolone and quinazolinone derivatives as agonists on human orl1 receptors
US5376661A (en) 3-aminochroman spiro compounds
EP1572672B1 (en) Benzoxazocines and their use as monoamine-reuptake inhibitors
EP0552386A1 (en) 2-Amino-3 or 6-methoxycyclohexyl amide derivatives
IE902750A1 (en) Coumarin derivatives, their preparation and their use in the¹treatment of cerebrovascular disorders
TW200524875A (en) Benzazepine derivatives as monoamine oxidase B inhibitors
KR930006777B1 (ko) 피리도[1,2-a]인돌 화합물 및 그 제조방법
AU607354B2 (en) Antipsychotic 4-(4-(3-benzisothiazolyl)-1-piperazinyl) butyl bridged bicyclic imides
AU622506B2 (en) Novel derivatives of 1,7-(imidazo-(1,2-a)pyridine)5'-6'h) ones
JPH0764843B2 (ja) 新規化合物，その製法及びそれを含む医薬組成物
KR810001501B1 (ko) 4a-아릴-옥타하이드로-1H-2-피리딘의 제조방법
AU644493B2 (en) Therapeutically useful 2-aminotetralin derivatives
JPH0615530B2 (ja) 多環式ベンズアゼピン
JP2000502051A (ja) ５ｈｔ▲下１ｄ▼レセプターアンタゴニストとしての三環系スピロ化合物

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 19940427

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 19940427